SEC Form 4 · accession 0001022079-18-000005
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J. E. Davis
Officer — EVP, General Diagnostics
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2018 | M | 63,880 | $52.165 | A | 101,423 | D | |
| Common StockF2,F3 | Jan 2, 2018 | S | 63,880 | $98.675 | D | 38,053 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F4 | $52.165 | Jan 2, 2018 | M | 63,880 | D | — | Feb 13, 2024 | Common Stock | 63,880 | 0 | D |
Explanation of responses
- F1This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017.
- F2This transaction was executed in multiple trades at prices ranging from $98.35 to $99.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F4The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017.